GW Pharmaceuticals Plc (GWPH)

170.88
4.86 2.77
NASDAQ : Health Technology
Prev Close 175.74
Open 175.69
Day Low/High 170.25 / 175.69
52 Wk Low/High 90.14 / 196.00
Volume 287.41K
Avg Volume 388.00K
Exchange NASDAQ
Shares Outstanding 30.72M
Market Cap 5.40B
EPS -10.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
'Mad Money' Lightning Round: Buy, Buy, Buy Bristol-Myers Squibb

'Mad Money' Lightning Round: Buy, Buy, Buy Bristol-Myers Squibb

Cramer still believes in Fitbit's long-term outlook but said Amicus Therapeutics is too speculative for him.

Jim Cramer's 'Mad Money' Recap: Commodities Are Healing, so Are Markets

Jim Cramer's 'Mad Money' Recap: Commodities Are Healing, so Are Markets

While many bears are dismissing the rally in commodity stocks as simple short covering, Cramer says there's actually a lot more in play.

Oversold Conditions For GW Pharmaceuticals (GWPH)

Oversold Conditions For GW Pharmaceuticals (GWPH)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of GW Pharmaceuticals Plc Of Class Action And A Lead Plaintiff Deadline Of March 21, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of GW Pharmaceuticals Plc Of Class Action And A Lead Plaintiff Deadline Of March 21, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of GW Pharmaceuticals plc ("GW Pharmaceuticals") (NASDAQ: GWPH)...

IMPORTANT SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In GW Pharmaceuticals PLC To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

IMPORTANT SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In GW Pharmaceuticals PLC To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

INVESTOR ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving GW Pharmaceuticals Plc And A Lead Plaintiff Deadline Of March 21, 2016

INVESTOR ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving GW Pharmaceuticals Plc And A Lead Plaintiff Deadline Of March 21, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased GW Pharmaceuticals plc (Nasdaq:GWPH) securities...

Jim Cramer's 'Mad Money' Recap: This Week's Game Plan

Jim Cramer's 'Mad Money' Recap: This Week's Game Plan

With a slightly less brutal backdrop for the stock market, Cramer says earnings can once again command the spotlight for this week's trading.

'Mad Money' Lightning Round: Cramer Likes FedEx and UPS

'Mad Money' Lightning Round: Cramer Likes FedEx and UPS

Cramer likes FedEx in addition to Dollar General and Dollar Tree, and thinks Cypress Semiconductor is too cheap.

STOCK ALERT: Rosen Law Firm Reminds GW Pharmaceuticals Plc Investors Of Important Deadline In Class Action - GWPH

STOCK ALERT: Rosen Law Firm Reminds GW Pharmaceuticals Plc Investors Of Important Deadline In Class Action - GWPH

Rosen Law Firm, a global investor rights law firm, reminds purchasers of GW Pharmaceuticals plc securities (NASDAQ: GWPH) from December 4, 2014 through January 8, 2016, both dates inclusive (the "Class Period") of the...

Mood Swing Tape Continues

Market internals hit upside trend day levels just one day after hitting downside trend day levels.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against GW Pharmaceuticals Plc - GWPH

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against GW Pharmaceuticals Plc - GWPH

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of GW Pharmaceuticals plc (NASDAQ:GWPH) securities from December 4, 2014 through January 8, 2016,...

8 Things That Could Lift Biotech Stocks Out of Bear Market

8 Things That Could Lift Biotech Stocks Out of Bear Market

Biotech stocks are buried in a deep hole. To climb out, companies will have to generate some positive news.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud By GW Pharmaceuticals Plc And Certain Officers And Directors

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud By GW Pharmaceuticals Plc And Certain Officers And Directors

Levi & Korsinsky, LLP announces that it has commenced an investigation of GW Pharmaceuticals plc ("GW Pharmaceuticals" or "the Company") (NASDAQ:GWPH) concerning possible violations of federal securities laws by the...

Jim Cramer Says Own Salesforce.com, Regeneron, First Solar

Jim Cramer Says Own Salesforce.com, Regeneron, First Solar

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer says Macy's should benefit from the cold weather and energy stocks are still 'too dangerous' to put money into.

This Is the Only Stock to Buy Right Now to Profit From Legalized Weed

This Is the Only Stock to Buy Right Now to Profit From Legalized Weed

Legalized cannabis is now the fastest-growing industry in the U.S. We highlight a "green rush" stock that analysts say will soar 124% next year.

'Mad Money' Lightning Round: It's OK to Buy Pandora Media Now

'Mad Money' Lightning Round: It's OK to Buy Pandora Media Now

Cramer is sticking with Bristol-Myers, is avoiding Marathon Oil and is a believer in Cypress Semiconductor.

Jim Cramer's 'Mad Money' Recap: Winners, Losers and the Chasm Between Them

Jim Cramer's 'Mad Money' Recap: Winners, Losers and the Chasm Between Them

There are haves and have-nots in every industry this year, Cramer says.

'Mad Money' Lightning Round: Take Mattel Over Hasbro

'Mad Money' Lightning Round: Take Mattel Over Hasbro

Cramer calls Raytheon one of the best military plays and GW Pharmaceuticals one of the most speculative stocks.

Jim Cramer's 'Mad Money' Recap: Play the Hand You're Dealt

Jim Cramer's 'Mad Money' Recap: Play the Hand You're Dealt

While some investors are throwing back all their cards and giving up, the skilled players are keeping what works and augmenting their hands with what'll keep working, Cramer says.

Jim Cramer Answers 8 Questions From Viewers Including CEO Henry Blodget

Jim Cramer Answers 8 Questions From Viewers Including CEO Henry Blodget

From the floor of the NSYE on Wednesday, Jim Cramer answered viewers' questions on the stock market, including questions on Tesla, Chipotle, Ford, PayPal, Under Armour and Lockheed Martin.

Jim Cramer Fields Questions From Viewers Including Henry Blodget

Jim Cramer Fields Questions From Viewers Including Henry Blodget

TheStreet's Jim Cramer tackled viewer questions on the economy from the NYSE Wednesday. His first viewer question was from Henry Blodget, an investor and CEO of Business Insider.

GW Pharmaceuticals Announces Date And Time Change For Q4 And Year-End 2015 Financial Results And Conference Call

GW Pharmaceuticals Announces Date And Time Change For Q4 And Year-End 2015 Financial Results And Conference Call

-Change to After Market on 7 December to Facilitate Inclusion of Additional Epidiolex Data-